Key result
Low-dose prasugrel single-antiplatelet therapy after short-term DAPT may provide a balanced strategy for preventing bleeding and ischemic events in high-bleeding risk patients after PCI.
Why the study?
Does short-term DAPT followed by P2Y12 inhibitor monotherapy reduce bleeding events without increasing ischemic events compared to long-term DAPT in high-bleeding risk patients after PCI?
Does short-term DAPT followed by P2Y12 inhibitor monotherapy reduce bleeding events without increasing ischemic events compared to long-term DAPT in high-bleeding risk patients after PCI?
Answers are grounded in this paper and cite their sources.
Short-term DAPT followed by P2Y12 inhibitor monotherapy is recommended for high-bleeding risk patients after PCI to reduce bleeding without increasing ischemic risk, though regional differences should be considered.
followed by P2Y12 inhibitor monotherapy because of the decrease in bleeding events and comparable incidence of ischemic events when compared with long-term DAPT.Because most of such pivotal trials have been conducted in foreign countries (except for STOPDAPT-2 trial), 1 it seems prudent to consider racial differences and country of origin R ecent guidelines of antithrombotic therapy in patients with coronary artery disease (CAD) recommend a shorter duration of dual-antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI).The Japanese Circulation Society's guideline 2020 focused update recommends 1-to 3-month DAPT after PCI, unless patients are at low bleeding risk and high thrombotic risk.Data from previous large-scale randomized controlled trials have supported short-term DAPT
No takes yet. Share an insight, caveat, or question.
Hideki Kitahara (2022) conducted an editorial in Coronary artery disease in high-bleeding risk patients after percutaneous coronary intervention. Prasugrel single-antiplatelet therapy after short-term DAPT vs. Long-term DAPT was evaluated. Low-dose prasugrel single-antiplatelet therapy after short-term DAPT may provide a balanced strategy for preventing bleeding and ischemic events in high-bleeding risk patients after PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: